Podcast: Can we develop better medicines for children faster?

Today we're asking Angelika Joos, Executive Director, Global Regulatory Policy, MSD "Can we develop better medicines for children faster?"

Over the last decade we have seen exciting new treatments or even cures for diseases impacting on children such as HIV, Hepatitis C, rheumatoid arthritis or certain cancers. These breakthroughs have been enabled by rapidly advancing science and the European Paediatric Regulation which created a framework to support the development of new medicines for children.

We mustn’t stop here. More can be done to increase the number of medicines available for children and we are currently working with other stakeholders to address paediatric needs.